Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 9641801, 8 pages
https://doi.org/10.1155/2017/9641801
Research Article

Evaluation of Epigallocatechin-3-gallate Modified Collagen Membrane and Concerns on Schwann Cells

1State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
2China-Japan Friendship Hospital, Department of Stomatology, Beijing 100029, China
3Department of Oral Implantology, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China

Correspondence should be addressed to Yi Man; moc.621@302087iynam and Yili Qu; moc.621@iliyqq

Received 17 April 2017; Revised 5 June 2017; Accepted 5 July 2017; Published 15 August 2017

Academic Editor: Zetao Chen

Copyright © 2017 Chenyu Chu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. Black, B. F. Lin, E. A. Wonder et al., “Biocompatibility and characterization of a peptide amphiphile hydrogel for applications in peripheral nerve regeneration,” Tissue Engineering - Part A, vol. 21, no. 7-8, pp. 1333–1342, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Z. Ray and S. E. Mackinnon, “Management of nerve gaps: autografts, allografts, nerve transfers, and end-to-side neurorrhaphy,” Experimental Neurology, vol. 223, no. 1, pp. 77–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Jiang, S. Jones, and X. Jia, “Stem cell transplantation for peripheral nerve regeneration: Current options and opportunities,” International Journal of Molecular Sciences, vol. 18, no. 1, article no. 94, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. J. N. Glenn, M. E. Miner, and L. F. Peltier, “The treatment of fractures of the femur in patients with head injuries,” Clinical Orthopaedics and Related Research, vol. 2004, no. 422, pp. 142–144, 1973. View at Google Scholar
  5. T. Yokoyama, T. Saino, N. Nakamuta, and Y. Yamamoto, “Topographic distribution of serotonin-immunoreactive urethral endocrine cells and their relationship with calcitonin gene-related peptide-immunoreactive nerves in male rats,” Acta Histochemica, vol. 119, no. 1, pp. 78–83, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Tonelli et al., “Bone regeneration in dentistry,” Clinical Cases in Mineral and Bone Metabolism, vol. 8, no. 3, pp. 24–28, 2011. View at Google Scholar
  7. H. Wang and L. Boyapati, “"pASS" principles for predictable bone regeneration,” Implant Dentistry, vol. 15, no. 1, pp. 8–17, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Chu et al., “Nanoparticles combined with growth factors: recent progress and applications,” RSC Advances, vol. 6, no. 93, pp. 90856–90872, 2016. View at Google Scholar
  9. D. J. Macaya, K. Hayakawa, K. Arai, and M. Spector, “Astrocyte infiltration into injectable collagen-based hydrogels containing FGF-2 to treat spinal cord injury,” Biomaterials, vol. 34, no. 14, pp. 3591–3602, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Cui, C. Lu, D. Meng et al., “Collagen scaffolds modified with CNTF and bFGF promote facial nerve regeneration in minipigs,” Biomaterials, vol. 35, no. 27, pp. 7819–7827, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Sadtler, K. Estrellas, B. W. Allen et al., “Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells,” Science, vol. 352, no. 6283, pp. 366–370, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Zhong, Y.-S. Chiou, M.-H. Pan, and F. Shahidi, “Anti-inflammatory activity of lipophilic epigallocatechin gallate (EGCG) derivatives in LPS-stimulated murine macrophages,” Food Chemistry, vol. 134, no. 2, pp. 742–748, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Riegsecker, D. Wiczynski, M. J. Kaplan, and S. Ahmed, “Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis,” Life Sciences, vol. 93, no. 8, pp. 307–312, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Nakamuta et al., “Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells,” International Journal of Molecular Medicine, vol. 16, no. 4, pp. 677–681, 2005. View at Google Scholar
  15. S.-H. Koh, S. H. Kim, H. Kwon et al., “Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3,” Molecular Brain Research, vol. 118, no. 1-2, pp. 72–81, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Xie, L. Jiang, T. Zhang, Y. Jin, D. Yang, and F. Chen, “Neuroprotective effects of Epigallocatechin-3-gallate (EGCG) in optic nerve crush model in rats,” Neuroscience Letters, vol. 479, no. 1, pp. 26–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. W. M. Renno, M. Al-Maghrebi, A. Alshammari, and P. George, “(-)-Epigallocatechin-3-gallate (EGCG) attenuates peripheral nerve degeneration in rat sciatic nerve crush injury,” Neurochemistry International, vol. 62, no. 3, pp. 221–231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Xifró, L. Vidal-Sancho, P. Boadas-Vaello et al., “Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice,” PLoS ONE, vol. 10, no. 4, Article ID e0123122, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Renno, K. Khan, and L. Benov, “Beneficial effect of (-)-epigallocatechin-3-gallate (EGCG) on sciatic nerve crush injury: stereological analysis,” The FASEB Journal, vol. 29, supplement 1, 2015. View at Google Scholar
  20. C. Chu et al., “Collagen membrane and immune response in guided bone regeneration: recent progress and perspectives,” Tissue Engineering Part B: Reviews, 2017. View at Publisher · View at Google Scholar
  21. C. Chu et al., “Evaluation of nano hydroxyapaptite (nano-HA) coated epigallocatechin-3-gallate (EGCG) cross-linked collagen membranes,” Materials Science and Engineering: C, vol. 78, pp. 258–264, 2017. View at Publisher · View at Google Scholar
  22. C. Chu, J. Deng, L. Xiang et al., “Evaluation of epigallocatechin-3-gallate (EGCG) cross-linked collagen membranes and concerns on osteoblasts,” Materials Science and Engineering C, vol. 67, pp. 386–394, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Svaren and D. Meijer, “The molecular machinery of myelin gene transcription in Schwann cells,” Glia, vol. 56, no. 14, pp. 1541–1551, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. E. LeBlanc, S.-W. Jang, R. M. Ward, L. Wrabetz, and J. Svaren, “Direct regulation of myelin protein zero expression by the Egr2 transactivator,” Journal of Biological Chemistry, vol. 281, no. 9, pp. 5453–5460, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Nagarajan, J. Svaren, N. Le, T. Araki, M. Watson, and J. Milbrandt, “EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression,” Neuron, vol. 30, no. 2, pp. 355–368, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Chenyu, J. Deng, Y. Hou et al., “Application of PEG and EGCG modified collagen-base membrane to promote osteoblasts proliferation,” Materials Science and Engineering C, vol. 76, pp. 31–36, 2017. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J. M. Kyriakis and J. Avruch, “Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update,” Physiological Reviews, vol. 92, no. 2, pp. 689–737, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Broggini, L. M. McManus, J. S. Hermann et al., “Peri-implant inflammation defined by the implant-abutment interface,” Journal of Dental Research, vol. 85, no. 5, pp. 473–478, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Albrektsson et al., “Is marginal bone loss around oral implants the result of a provoked foreign body reaction?” Clinical Implant Dentistry & Related Research, vol. 16, article 155, no. 2, 2014. View at Google Scholar
  31. K. Venken, E. Di Maria, E. Bellone et al., “Search for mutations in the EGR2 corepressor proteins, NAB1 and NAB2, in human peripheral neuropathies,” Neurogenetics, vol. 4, no. 1, pp. 37–41, 2002. View at Publisher · View at Google Scholar · View at Scopus